Our client is a platform-driven, clinical-stage biotechnology company that is mapping human longevity to change the nature of aging and extend healthy lifespan. Our growing portfolio of therapeutics for immune, muscle, and brain aging includes four drug programs, two first-in-class and two first-in-indication. Our vision is “growing older without aging” - a future in which aging allows us to pursue our goals, accumulate new experiences and accomplishments, and actively contribute to society without disease, physical disability, or loss of independence and connection. A leading company in the emerging...